Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nankai Yungong Pharmaceutical is a pharmaceutical company based in Tianjin, China, and is an industrial enterprise affiliated with the Nankai University Drug Research Center. Founded in 2005, the company focuses on the research, development, and manufacturing of chemical raw materials and sterile injection preparations, including small-capacity injections and lyophilized powders. Its commercial portfolio features cardiovascular treatments such as Tirofiban Hydrochloride Injection and analgesics like Ibuprofen Injection. The company leverages its close ties with Nankai University's School of Pharmacy to bridge academic research with industrial production, maintaining GMP-certified facilities for a variety of therapeutic areas. Nankai Yungong Pharmaceutical is particularly active in the development of generic and improved formulations for acute care and chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nankai Yungong Pharmaceutical.